These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 34544677)

  • 1. Establishment and application of population pharmacokinetics model of vancomycin in infants with meningitis.
    Xu J; Zhu Y; Niu P; Liu Y; Li D; Jiang L; Shi D
    Pediatr Neonatol; 2022 Jan; 63(1):57-65. PubMed ID: 34544677
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Population pharmacokinetics of vancomycin in adult Chinese patients with post-craniotomy meningitis and its application in individualised dosage regimens.
    Lin WW; Wu W; Jiao Z; Lin RF; Jiang CZ; Huang PF; Liu YW; Wang CL
    Eur J Clin Pharmacol; 2016 Jan; 72(1):29-37. PubMed ID: 26423622
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Predictive performance of reported vancomycin population pharmacokinetic model in patients with different renal function status, especially those with augmented renal clearance.
    Yu YX; Lu J; Lu HD; Li L; Li JJ; Shi L; Duan LF; Zhuang ZW; Xue SD; Shen Y; Tang L
    Eur J Hosp Pharm; 2022 Mar; 29(e1):e6-e14. PubMed ID: 33414258
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Population pharmacokinetics of vancomycin in Chinese patients with augmented renal clearance.
    Chu Y; Luo Y; Ji S; Jiang M; Zhou B
    J Infect Public Health; 2020 Jan; 13(1):68-74. PubMed ID: 31277936
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development of Vancomycin Dose Individualization Strategy by Bayesian Prediction in Patients Receiving Continuous Renal Replacement Therapy.
    Oda K; Jono H; Kamohara H; Nishi K; Tanoue N; Saito H
    Pharm Res; 2020 May; 37(6):108. PubMed ID: 32468340
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Establishment of a population pharmacokinetics model of vancomycin in 94 infants with septicemia and its application in individualized therapy.
    Li Z; Li H; Wang C; Jiao Z; Xu F; Sun H
    BMC Pharmacol Toxicol; 2021 May; 22(1):26. PubMed ID: 33947475
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vancomycin in neonatal sepsis: predictive performance of a Chinese neonatal population pharmacokinetic model and clinical efficacy evaluation.
    Weng XH; Zhu CQ; Duan LF; Li L; Yang ZM; Wang SN; Cai Y; Li JJ; Yu YX; Feng ZT; Tang L
    Eur J Hosp Pharm; 2022 Mar; 29(2):101-108. PubMed ID: 33472817
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Population pharmacokinetics of vancomycin in Chinese infants
.
    Sheng XY; Chen CY; Ma LY; Liu YO; Zhou Y; Cui YM
    Int J Clin Pharmacol Ther; 2017 Jul; 55(7):558-566. PubMed ID: 28406088
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Population pharmacokinetics of vancomycin and AUC-guided dosing in Chinese neonates and young infants.
    Chen Y; Wu D; Dong M; Zhu Y; Lu J; Li X; Chen C; Li Z
    Eur J Clin Pharmacol; 2018 Jul; 74(7):921-930. PubMed ID: 29602981
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of Bayesian predictability of vancomycin concentration using population pharmacokinetic parameters in pediatric patients.
    Ohnishi A; Yano Y; Ishibashi T; Katsube T; Oguma T
    Drug Metab Pharmacokinet; 2005 Dec; 20(6):415-22. PubMed ID: 16415526
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Population Pharmacokinetic Study of Vancomycin in Chinese Pediatric Patients with Hematological Malignancies.
    Wang H; Huang L; Wang J; Ni Y; Zhu Z; Gao P; Hu Y; Zhang L; Yang J; Fang L
    Pharmacotherapy; 2020 Dec; 40(12):1201-1209. PubMed ID: 33070357
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Low vancomycin trough concentration in neonates and young infants.
    Maruyama H; Tanzawa A; Funaki T; Ito Y; Isayama T
    Pediatr Int; 2021 May; 63(5):556-560. PubMed ID: 32894884
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Population pharmacokinetics of lamotrigine co-administered with valproic acid in Chinese epileptic children using nonlinear mixed effects modeling.
    Xu S; Liu L; Chen Y; Liu M; Lu T; Wang H; Liu S; Zhao M; Zhao L
    Eur J Clin Pharmacol; 2018 May; 74(5):583-591. PubMed ID: 29340733
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Duration of Systemic Inflammatory Response Syndrome Influences Serum Vancomycin Concentration in Patients With Sepsis.
    Chuma M; Makishima M; Imai T; Tochikura N; Sakaue T; Kikuchi N; Kinoshita K; Kaburaki M; Yoshida Y
    Clin Ther; 2016 Dec; 38(12):2598-2609. PubMed ID: 27836495
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vancomycin pharmacokinetics in neonates and infants: a retrospective evaluation.
    Asbury WH; Darsey EH; Rose WB; Murphy JE; Buffington DE; Capers CC
    Ann Pharmacother; 1993 Apr; 27(4):490-6. PubMed ID: 8477127
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A population pharmacokinetic model of vancomycin for dose individualization based on serum cystatin C as a marker of renal function.
    Liu TT; Pang HM; Jing L; Wei WX; Qin XL; Guo Q; Lu H; Cheng DH; Jiang WZ
    J Pharm Pharmacol; 2019 Jun; 71(6):945-955. PubMed ID: 30873627
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Population pharmacokinetic analysis of vancomycin in neonates. A new proposal of initial dosage guideline.
    Marqués-Miñana MR; Saadeddin A; Peris JE
    Br J Clin Pharmacol; 2010 Nov; 70(5):713-20. PubMed ID: 21039765
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Initial dosage regimens of vancomycin for Chinese adult patients based on population pharmacokinetic analysis.
    Deng C; Liu T; Zhou T; Lu H; Cheng D; Zhong X; Lu W
    Int J Clin Pharmacol Ther; 2013 May; 51(5):407-15. PubMed ID: 23458230
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vancomycin population pharmacokinetics and dosing recommendations in haematologic malignancy with augmented renal clearance children.
    Lv CL; Lu JJ; Chen M; Zhang R; Li QC; Chen YY; Liu TT
    J Clin Pharm Ther; 2020 Dec; 45(6):1278-1287. PubMed ID: 32557716
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Regression Model to Predict Augmented Renal Clearance in Critically Ill Obstetric Patients and Effects on Vancomycin Treatment.
    Tang L; Ding XY; Duan LF; Li L; Lu HD; Zhou F; Shi L; Lu J; Shen Y; Zhuang ZW; Sun JT; Zhou Q; Zhu CQ; Li JJ; Yu YX
    Front Pharmacol; 2021; 12():622948. PubMed ID: 34177564
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.